Imaging test for kidney cancer and related tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new imaging agent that may help doctors see kidney cancer and certain other tumors more clearly on PET/CT scans. It could help find cancer that has spread or come back after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to have kidney cancer, suspected kidney cancer, or a specific type of tumor (like breast or nasopharyngeal cancer).
- You must have at least one tumor that can be measured on a scan.
- You should be able to care for yourself (performance status 0-2).
- You must agree to use birth control during the study and for 6 months after, if you could have children.
- You must be able to lie still for a PET/CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan to better see kidney tumors. It may help doctors understand the tumor better before biopsy or surgery.
This trial tests a new imaging agent (68Ga-NYM096) that may help doctors see whether a kidney mass is cancer before surgery. By undergoing a PET/CT scan with this agent, you might help doctors better plan your surgery and avoid unnecessary procedures.
This trial uses a special PET scan to see if kidney cancer remains or has come back after treatment. The scan helps doctors find cancer cells more precisely, which may guide better treatment decisions.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This Phase 1 study tests whether a special PET/CT scan drug ([18F]PT2385) can help doctors see kidney cancer and related tumors. It may help guide diagnosis and treatment decisions, especially in people planning surgery or starting belzutifan.
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
Hear when a new Renal Cell Carcinoma (RCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.